Oculis Holding AG (OCS)
NASDAQ: OCS · Real-Time Price · USD
28.72
+0.36 (1.29%)
Feb 10, 2026, 1:14 PM EST - Market open
Oculis Holding AG Market Cap
Oculis Holding AG has a market cap or net worth of $1.66 billion as of February 10, 2026. Its market cap has increased by 75.81% in one year.
Market Cap
1.66B
Enterprise Value
1.46B
1-Year Change
75.81%
Ranking
Category
Stock Price
$28.72
Market Cap Chart
Since May 18, 2021, Oculis Holding AG's market cap has increased from $159.07M to $1.66B, an increase of 943.54%. That is a compound annual growth rate of 64.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 1.64B | 41.96% |
| Dec 31, 2025 | 1.15B | 61.89% |
| Dec 31, 2024 | 713.06M | 73.50% |
| Dec 29, 2023 | 411.00M | 148.15% |
| Dec 30, 2022 | 165.63M | 4.23% |
| Dec 28, 2021 | 158.90M | -0.10% |
| May 18, 2021 | 159.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Corvus Pharmaceuticals | 1.71B |
| Zymeworks | 1.70B |
| MBX Biosciences | 1.69B |
| Tango Therapeutics | 1.68B |
| Definium Therapeutics | 1.66B |
| Tyra Biosciences | 1.65B |
| Innoviva | 1.63B |
| Immunocore Holdings | 1.62B |